ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

OPY Oppenheimer Holdings Inc

46.67
0.26 (0.56%)
26 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Oppenheimer Holdings Inc NYSE:OPY NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.26 0.56% 46.67 46.762 46.14 46.23 41,157 23:48:02

Oppenheimer Expands Its Global Investment Banking Capabilities with the Addition of Martin Chamberlin

04/06/2024 11:00am

PR Newswire (US)


Oppenheimer (NYSE:OPY)
Historical Stock Chart


From Jun 2024 to Jun 2024

Click Here for more Oppenheimer Charts.

Highly experienced, London-based banker to lead firm's newly established Healthcare M&A practice

NEW YORK, June 4, 2024 /PRNewswire/ -- Oppenheimer Europe (Oppenheimer) — a subsidiary of Oppenheimer Holdings, the leading investment bank and wealth manager (NYSE: OPY) — announced today a further expansion of its European investment banking footprint with the addition of Martin Chamberlin.

Based in London, Chamberlin will serve as a Managing Director and Head of European Healthcare. In that role, he will lead the firm's newly established European healthcare practice and report to Max Lami, Chief Executive Officer of Oppenheimer Europe.

"Martin's arrival comes at a key time for Oppenheimer, allowing the firm to service our clients in Europe in the strategically important healthcare sector," Lami said. "As we continue to cement Oppenheimer as a leading global advisory and capital markets firm, Martin will build a European-based practice that will complement our highly successful healthcare investment banking business in North America."

Chamberlin joins Oppenheimer with over 20 years of experience. During his career, he has advised a broad range of corporate, private equity and infrastructure fund clients across the healthcare space. Most recently, Chamberlin was a Managing Director with RBC Capital Markets, where he worked on the firm's European Healthcare Investment Banking team.

"I am excited to start working with Martin," said Leigh Webb, Managing Director and Head of Financial Sponsor Coverage for Europe. "As the firm continues to establish itself as a key strategic advisor to M&A-focused private equity funds and fund placement advisory groups in the UK and across Europe, Martin's extensive track record in the healthcare sector will enable us to partner with a wide variety of funds looking to acquire platform businesses and get the most out of their healthcare assets."

Oppenheimer & Co. Inc.
Oppenheimer & Co. Inc. (Oppenheimer), a principal subsidiary of Oppenheimer Holdings Inc. (OPY on the New York Stock Exchange), and its affiliates provide a full range of wealth management, securities brokerage and investment banking services to high net-worth individuals, families, corporate executives, local governments, businesses and institutions.

Oppenheimer Europe Limited
Oppenheimer Europe Limited (Oppenheimer), a subsidiary of Oppenheimer Holdings Inc. (OPY on the New York Stock Exchange) provides financial services to EMEA-based institutions and corporations across corporate finance, equities, fixed income, debt capital markets and portfolio strategy research.

Contact:
Michael Dugan
Haven Tower Group LLC
424 317 4852
mdugan@haventower.com

Cision View original content:https://www.prnewswire.co.uk/news-releases/oppenheimer-expands-its-global-investment-banking-capabilities-with-the-addition-of-martin-chamberlin-302162629.html

Copyright 2024 PR Newswire

1 Year Oppenheimer Chart

1 Year Oppenheimer Chart

1 Month Oppenheimer Chart

1 Month Oppenheimer Chart

Your Recent History

Delayed Upgrade Clock